Welcome

Annual General Meeting Carl Zeiss Meditec AG

Thursday, 21 March 2024

348.1

million Euro EBIT in fiscal year 2022/23

16.7%

EBIT margin in fiscal year 2022/23

OphthalmologyMicrosurgery

1,576.5 512.8

million Euro revenue in fiscal year 2022/23

million Euro revenue in fiscal year 2022/23

+7.3% +18.3%

sales growth

sales growth

47.9 %

of total revenue

24.8 %

of total revenue

27.3 %

of total revenue

APAC

EMEA

Americas

1,001.2

517.3

570.7

million Euro sales

million Euro sales

million Euro sales

+4.6%

+12.7%

+17.2%

sales growth

sales growth

sales growth

2,089.3

million Euro revenue in fiscal year 2022/23

1

2

3

INNOVATIVE STRENGTH

CUSTOMER FOCUS

LONG-TERM CORPORATE STRATEGY

INNOVATIVE STRENGTH

INNOVATIVE STRENGTH

INNOVATIVE STRENGTH

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Carl Zeiss Meditec AG published this content on 22 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 April 2024 15:38:05 UTC.